We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 1113 (+2)

2% more funds holding

Funds holding: 283288 (+5)

0.07% more ownership

Funds ownership: 94.92%94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M
Name Holding Trade Value Shares
Change
Change in
Stake
S
276
Sachetta
Massachusetts
$1.18K +$464 +5 +71%
CA
277
Continuum Advisory
Idaho
$1.1K
PWMG
278
Private Wealth Management Group
New Jersey
$1.1K +$1.11K +12 New
FMP
279
Financial Management Professionals
Texas
$1K
CFGS
280
Concourse Financial Group Securities
Alabama
$642 +$650 +7 New
SIC
281
SJS Investment Consulting
Ohio
$551
DPW
282
DiNuzzo Private Wealth
Pennsylvania
$368
FHA
283
First Horizon Advisors
Tennessee
$367 -$1.76K -19 -83%
CJ
284
Caitlin John
Michigan
$367 +$186 +2 +100%
MCM
285
MV Capital Management
Maryland
$276 +$278 +3 New
GI
286
GAMMA Investing
California
$275 -$1.76K -19 -86%
BGAI
287
Bruce G. Allen Investments
Colorado
$184 -$650 -7 -78%
Boston Partners
288
Boston Partners
Massachusetts
-$18.3M -198,827 Closed
LI
289
Leeward Investments
Massachusetts
-$9.47M -102,789 Closed
NYLIM
290
New York Life Investment Management
New York
-$7.09M -76,931 Closed
Hudson Bay Capital Management
291
Hudson Bay Capital Management
Connecticut
-$7.01M -76,026 Closed
EP
292
Edgestream Partners
New Jersey
-$4.56M -49,482 Closed
AIG
293
American International Group
New York
-$3.98M -43,192 Closed
PAMP
294
Polar Asset Management Partners
Ontario, Canada
-$3M -32,500 Closed
TPSF
295
Texas Permanent School Fund
Texas
-$2.63M -28,560 Closed
PA
296
Paralel Advisors
Colorado
-$2.4M -26,002 Closed
MCM
297
Moore Capital Management
New York
-$1.57M -17,000 Closed
CSS
298
Cubist Systematic Strategies
Connecticut
-$1.37M -14,874 Closed
CWM
299
CIBC World Markets
New York
-$1.2M -13,037 Closed
DTL
300
Dynamic Technology Lab
Singapore
-$881K -9,553 Closed

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.